Evogene to Present at Jefferies Virtual Industrials Conference, 2021
Evogene Ltd. (NASDAQ: EVGN) announced that President and CEO Ofer Haviv will present at the Jefferies Virtual Industrials Conference on August 3, 2021, at 09:00 AM EST. The presentation will highlight Evogene's disruptive technologies and tailored engines for product discovery across its subsidiaries. Investors interested in meeting Mr. Haviv can contact Evogene's Investor Relations team. Evogene is focused on revolutionizing life-science product development using its Computational Predictive Biology platform, targeting sectors like human health and agriculture.
- None.
- None.
REHOVOT, Israel, July 29, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announced today that Ofer Haviv, Evogene's President and CEO, will present at the Jefferies Virtual Industrials Conference, 2021 taking place on August 3-4,2021. Mr. Haviv's presentation will focus on Evogene's disruptive technologies; its tailor-made engines for product discovery and development and its fields of activity through its main subsidiaries and will take place on Tuesday, August 3, 2021, at 09:00 am, EST.
Investors attending the conference who wish to meet with Mr. Haviv, may contact Evogene's Investor Relations team at ir@evogene.com or through the conference's online meeting platform.
About Evogene Ltd.:
Evogene (NASDAQ: EVGN) (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ltd. For more information, please visit www.evogene.com.
Evogene Investor Contact: | US Investor Relations: |
Aviva Banczewski/ Rivka Neufeld Investor Relations and Public Relations Manager T: +972-8-931-1940 | Joseph Green |
Laine Yonker Edison Group T: +1 646-653-7035 |
View original content:https://www.prnewswire.com/news-releases/evogene-to-present-at-jefferies-virtual-industrials-conference-2021-301344086.html
SOURCE Evogene
